SCHEMBL6544085

SCHEMBL6544085

[c]1ncc(-c2cc[nH]n2)c(-c2c[nH]nn2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL558262 0.78 AKT1 (0.35)
SCHEMBL558261 0.75 AKT1 (0.35)
SCHEMBL7453710 0.72
SCHEMBL4971002 0.71 MAPT (0.36)
SCHEMBL17354059 0.71 PTPRC (0.33)
SCHEMBL1521877 0.66
SCHEMBL558883 0.64
SCHEMBL2420409 0.62
SCHEMBL20985612 0.60
Pyrazine SCHEMBL28088037 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6756378-B2 BENZYL -UREA, -THIOUREA, OR -GUANIDINE DERIVATIVES THAT INHIBIT THE BINDING OF LIGANDS TO ALPHA 4 BETA 1 INTEGRIN (VLA-4) PHARMACOPEIA DRUG DISCOVERY, INC. 2004-06-29 US disclosed
US-20030078249-A1 VLA-4 inhibitor compounds DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-04-24 US disclosed